nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—ADRA1A—hypertension	0.195	0.512	CbGaD
Droperidol—DRD2—hypertension	0.105	0.275	CbGaD
Droperidol—HTR2A—hypertension	0.0809	0.213	CbGaD
Droperidol—KCNH2—Terazosin—hypertension	0.0462	0.121	CbGbCtD
Droperidol—KCNH2—Doxazosin—hypertension	0.0385	0.101	CbGbCtD
Droperidol—KCNH2—Bepridil—hypertension	0.0332	0.0869	CbGbCtD
Droperidol—KCNH2—Prazosin—hypertension	0.0317	0.0829	CbGbCtD
Droperidol—ADRA1A—Terazosin—hypertension	0.0313	0.082	CbGbCtD
Droperidol—ADRA1A—Fenoldopam—hypertension	0.0283	0.0742	CbGbCtD
Droperidol—KCNH2—Carvedilol—hypertension	0.0273	0.0716	CbGbCtD
Droperidol—DRD2—Fenoldopam—hypertension	0.0272	0.0713	CbGbCtD
Droperidol—ADRA1A—Doxazosin—hypertension	0.0261	0.0685	CbGbCtD
Droperidol—ADRA1A—Prazosin—hypertension	0.0215	0.0562	CbGbCtD
Droperidol—ADRA1A—Nicardipine—hypertension	0.0185	0.0485	CbGbCtD
Droperidol—ADRA1A—Carvedilol—hypertension	0.0185	0.0485	CbGbCtD
Droperidol—KCNH2—Verapamil—hypertension	0.0173	0.0452	CbGbCtD
Droperidol—ADRA1A—Clonidine—hypertension	0.0163	0.0426	CbGbCtD
Droperidol—HTR2A—arteriole—hypertension	0.00328	0.111	CbGeAlD
Droperidol—HTR2A—locus ceruleus—hypertension	0.00264	0.0897	CbGeAlD
Droperidol—HTR2A—pulmonary artery—hypertension	0.00215	0.0729	CbGeAlD
Droperidol—HTR2A—sympathetic nervous system—hypertension	0.00209	0.0709	CbGeAlD
Droperidol—HTR2A—vagus nerve—hypertension	0.00202	0.0687	CbGeAlD
Droperidol—HTR2A—vein—hypertension	0.00195	0.0663	CbGeAlD
Droperidol—HTR2A—autonomic nervous system—hypertension	0.0014	0.0477	CbGeAlD
Droperidol—HTR2A—hindlimb—hypertension	0.0013	0.0441	CbGeAlD
Droperidol—HTR2A—urine—hypertension	0.00114	0.0388	CbGeAlD
Droperidol—HTR2A—artery—hypertension	0.000796	0.027	CbGeAlD
Droperidol—HTR2A—endothelium—hypertension	0.000672	0.0228	CbGeAlD
Droperidol—KCNH2—cardiac ventricle—hypertension	0.000667	0.0226	CbGeAlD
Droperidol—KCNH2—myocardium—hypertension	0.000627	0.0213	CbGeAlD
Droperidol—HTR2A—blood vessel—hypertension	0.00062	0.0211	CbGeAlD
Droperidol—ADRA1A—brainstem—hypertension	0.000524	0.0178	CbGeAlD
Droperidol—DRD2—brainstem—hypertension	0.000514	0.0174	CbGeAlD
Droperidol—ADRA1A—heart—hypertension	0.000453	0.0154	CbGeAlD
Droperidol—KCNH2—heart—hypertension	0.000438	0.0149	CbGeAlD
Droperidol—ADRA1A—cardiovascular system—hypertension	0.000428	0.0145	CbGeAlD
Droperidol—Pimozide—CALM2—hypertension	0.000424	0.116	CrCbGaD
Droperidol—KCNH2—cardiovascular system—hypertension	0.000413	0.014	CbGeAlD
Droperidol—KCNH2—cardiac atrium—hypertension	0.000374	0.0127	CbGeAlD
Droperidol—KCNH2—medulla oblongata—hypertension	0.000353	0.012	CbGeAlD
Droperidol—HTR2A—brainstem—hypertension	0.000339	0.0115	CbGeAlD
Droperidol—ADRA1A—adrenal gland—hypertension	0.000338	0.0115	CbGeAlD
Droperidol—KCNH2—adrenal gland—hypertension	0.000327	0.0111	CbGeAlD
Droperidol—Fluspirilene—HTR2B—hypertension	0.000312	0.0849	CrCbGaD
Droperidol—ADRA1A—endocrine gland—hypertension	0.000293	0.00996	CbGeAlD
Droperidol—HTR2A—heart—hypertension	0.000293	0.00995	CbGeAlD
Droperidol—HTR2A—smooth muscle tissue—hypertension	0.000291	0.00987	CbGeAlD
Droperidol—DRD2—endocrine gland—hypertension	0.000288	0.00977	CbGeAlD
Droperidol—KCNH2—endocrine gland—hypertension	0.000283	0.00962	CbGeAlD
Droperidol—HTR2A—cardiovascular system—hypertension	0.000277	0.00939	CbGeAlD
Droperidol—Pimozide—CALM1—hypertension	0.000273	0.0744	CrCbGaD
Droperidol—HTR2A—kidney—hypertension	0.000271	0.00919	CbGeAlD
Droperidol—ADRA1A—central nervous system—hypertension	0.000264	0.00898	CbGeAlD
Droperidol—DRD2—central nervous system—hypertension	0.000259	0.0088	CbGeAlD
Droperidol—KCNH2—central nervous system—hypertension	0.000255	0.00867	CbGeAlD
Droperidol—HTR2A—medulla oblongata—hypertension	0.000236	0.00802	CbGeAlD
Droperidol—HTR2A—adrenal gland—hypertension	0.000219	0.00743	CbGeAlD
Droperidol—Haloperidol—HTR2B—hypertension	0.000213	0.0579	CrCbGaD
Droperidol—Fenbufen—PTGS1—hypertension	0.000192	0.0523	CrCbGaD
Droperidol—HTR2A—endocrine gland—hypertension	0.00019	0.00644	CbGeAlD
Droperidol—HTR2A—central nervous system—hypertension	0.000171	0.0058	CbGeAlD
Droperidol—Fluspirilene—ADRA2A—hypertension	0.000166	0.0451	CrCbGaD
Droperidol—Fluspirilene—ADRB1—hypertension	0.000165	0.045	CrCbGaD
Droperidol—Domperidone—DRD3—hypertension	0.000162	0.0442	CrCbGaD
Droperidol—Domperidone—CYP3A5—hypertension	0.000157	0.0428	CrCbGaD
Droperidol—Pimozide—DRD3—hypertension	0.000136	0.0369	CrCbGaD
Droperidol—Pimozide—CYP3A5—hypertension	0.000132	0.0358	CrCbGaD
Droperidol—Haloperidol—HTR1B—hypertension	0.000128	0.0347	CrCbGaD
Droperidol—Fluspirilene—SLC6A4—hypertension	0.000126	0.0344	CrCbGaD
Droperidol—Fluspirilene—DRD2—hypertension	0.000126	0.0342	CrCbGaD
Droperidol—Haloperidol—DRD3—hypertension	0.000124	0.0337	CrCbGaD
Droperidol—Haloperidol—CYP3A5—hypertension	0.00012	0.0327	CrCbGaD
Droperidol—Domperidone—DRD2—hypertension	0.000112	0.0306	CrCbGaD
Droperidol—Fenbufen—PTGS2—hypertension	0.00011	0.0299	CrCbGaD
Droperidol—Fluspirilene—HTR2A—hypertension	9.71e-05	0.0264	CrCbGaD
Droperidol—Pimozide—DRD2—hypertension	9.39e-05	0.0256	CrCbGaD
Droperidol—Haloperidol—DRD2—hypertension	8.57e-05	0.0233	CrCbGaD
Droperidol—Haloperidol—CYP1A1—hypertension	8.14e-05	0.0222	CrCbGaD
Droperidol—Anxiety—Telmisartan—hypertension	8.03e-05	0.000602	CcSEcCtD
Droperidol—Syncope—Perindopril—hypertension	8.01e-05	0.0006	CcSEcCtD
Droperidol—Syncope—Irbesartan—hypertension	7.98e-05	0.000598	CcSEcCtD
Droperidol—Rash—Terazosin—hypertension	7.94e-05	0.000595	CcSEcCtD
Droperidol—Dermatitis—Terazosin—hypertension	7.93e-05	0.000594	CcSEcCtD
Droperidol—Shock—Clonidine—hypertension	7.93e-05	0.000594	CcSEcCtD
Droperidol—Hypersensitivity—Guanabenz—hypertension	7.92e-05	0.000594	CcSEcCtD
Droperidol—Hypersensitivity—Metoprolol—hypertension	7.92e-05	0.000594	CcSEcCtD
Droperidol—Syncope—Hydrochlorothiazide—hypertension	7.92e-05	0.000594	CcSEcCtD
Droperidol—Hypotension—Valsartan—hypertension	7.9e-05	0.000592	CcSEcCtD
Droperidol—Palpitations—Perindopril—hypertension	7.89e-05	0.000592	CcSEcCtD
Droperidol—Tachycardia—Clonidine—hypertension	7.86e-05	0.00059	CcSEcCtD
Droperidol—Hypotension—Olmesartan—hypertension	7.86e-05	0.000589	CcSEcCtD
Droperidol—Loss of consciousness—Perindopril—hypertension	7.85e-05	0.000588	CcSEcCtD
Droperidol—Anaphylactic shock—Enalapril—hypertension	7.83e-05	0.000587	CcSEcCtD
Droperidol—Loss of consciousness—Irbesartan—hypertension	7.82e-05	0.000587	CcSEcCtD
Droperidol—Body temperature increased—Propranolol—hypertension	7.8e-05	0.000585	CcSEcCtD
Droperidol—Palpitations—Hydrochlorothiazide—hypertension	7.8e-05	0.000585	CcSEcCtD
Droperidol—Dizziness—Eprosartan—hypertension	7.79e-05	0.000584	CcSEcCtD
Droperidol—Loss of consciousness—Hydrochlorothiazide—hypertension	7.76e-05	0.000582	CcSEcCtD
Droperidol—Rash—Acebutolol—hypertension	7.74e-05	0.00058	CcSEcCtD
Droperidol—Shock—Trandolapril—hypertension	7.73e-05	0.00058	CcSEcCtD
Droperidol—Dermatitis—Acebutolol—hypertension	7.73e-05	0.000579	CcSEcCtD
Droperidol—Anaphylactic shock—Telmisartan—hypertension	7.72e-05	0.000579	CcSEcCtD
Droperidol—Hypertension—Perindopril—hypertension	7.71e-05	0.000578	CcSEcCtD
Droperidol—Syncope—Betaxolol—hypertension	7.71e-05	0.000578	CcSEcCtD
Droperidol—Shock—Enalapril—hypertension	7.7e-05	0.000577	CcSEcCtD
Droperidol—Hypertension—Irbesartan—hypertension	7.68e-05	0.000576	CcSEcCtD
Droperidol—Tachycardia—Trandolapril—hypertension	7.67e-05	0.000575	CcSEcCtD
Droperidol—Rash—Labetalol—hypertension	7.67e-05	0.000575	CcSEcCtD
Droperidol—Dermatitis—Labetalol—hypertension	7.66e-05	0.000574	CcSEcCtD
Droperidol—Angioedema—Losartan—hypertension	7.65e-05	0.000574	CcSEcCtD
Droperidol—Tachycardia—Enalapril—hypertension	7.64e-05	0.000573	CcSEcCtD
Droperidol—Palpitations—Betaxolol—hypertension	7.6e-05	0.000569	CcSEcCtD
Droperidol—Shock—Telmisartan—hypertension	7.6e-05	0.000569	CcSEcCtD
Droperidol—Anxiety—Perindopril—hypertension	7.58e-05	0.000568	CcSEcCtD
Droperidol—Dizziness—Amlodipine—hypertension	7.56e-05	0.000567	CcSEcCtD
Droperidol—Dizziness—Nisoldipine—hypertension	7.56e-05	0.000567	CcSEcCtD
Droperidol—Loss of consciousness—Betaxolol—hypertension	7.55e-05	0.000566	CcSEcCtD
Droperidol—Body temperature increased—Indapamide—hypertension	7.55e-05	0.000566	CcSEcCtD
Droperidol—Body temperature increased—Diltiazem—hypertension	7.55e-05	0.000566	CcSEcCtD
Droperidol—Anxiety—Irbesartan—hypertension	7.55e-05	0.000566	CcSEcCtD
Droperidol—Tachycardia—Telmisartan—hypertension	7.53e-05	0.000565	CcSEcCtD
Droperidol—Hypotension—Clonidine—hypertension	7.53e-05	0.000564	CcSEcCtD
Droperidol—Somnolence—Valsartan—hypertension	7.51e-05	0.000563	CcSEcCtD
Droperidol—Syncope—Losartan—hypertension	7.51e-05	0.000563	CcSEcCtD
Droperidol—Anaphylactic shock—Captopril—hypertension	7.51e-05	0.000563	CcSEcCtD
Droperidol—Anxiety—Hydrochlorothiazide—hypertension	7.49e-05	0.000562	CcSEcCtD
Droperidol—Body temperature increased—Carvedilol—hypertension	7.48e-05	0.000561	CcSEcCtD
Droperidol—Hallucination—Lisinopril—hypertension	7.45e-05	0.000558	CcSEcCtD
Droperidol—Rash—Eprosartan—hypertension	7.43e-05	0.000557	CcSEcCtD
Droperidol—Dermatitis—Eprosartan—hypertension	7.42e-05	0.000556	CcSEcCtD
Droperidol—Palpitations—Losartan—hypertension	7.4e-05	0.000555	CcSEcCtD
Droperidol—Body temperature increased—Doxazosin—hypertension	7.4e-05	0.000555	CcSEcCtD
Droperidol—Shock—Captopril—hypertension	7.39e-05	0.000554	CcSEcCtD
Droperidol—Loss of consciousness—Losartan—hypertension	7.36e-05	0.000552	CcSEcCtD
Droperidol—Hypotension—Trandolapril—hypertension	7.34e-05	0.000551	CcSEcCtD
Droperidol—Tachycardia—Captopril—hypertension	7.33e-05	0.000549	CcSEcCtD
Droperidol—Hypotension—Enalapril—hypertension	7.31e-05	0.000548	CcSEcCtD
Droperidol—Body temperature increased—Fosinopril—hypertension	7.31e-05	0.000548	CcSEcCtD
Droperidol—Anxiety—Betaxolol—hypertension	7.29e-05	0.000547	CcSEcCtD
Droperidol—Anaphylactic shock—Perindopril—hypertension	7.29e-05	0.000546	CcSEcCtD
Droperidol—Hypersensitivity—Propranolol—hypertension	7.27e-05	0.000545	CcSEcCtD
Droperidol—Anaphylactic shock—Irbesartan—hypertension	7.26e-05	0.000545	CcSEcCtD
Droperidol—Body temperature increased—Eplerenone—hypertension	7.26e-05	0.000544	CcSEcCtD
Droperidol—Pimozide—HTR2A—hypertension	7.26e-05	0.0198	CrCbGaD
Droperidol—Hypotension—Telmisartan—hypertension	7.21e-05	0.000541	CcSEcCtD
Droperidol—Rash—Nisoldipine—hypertension	7.21e-05	0.000541	CcSEcCtD
Droperidol—Rash—Amlodipine—hypertension	7.21e-05	0.000541	CcSEcCtD
Droperidol—Body temperature increased—Nifedipine—hypertension	7.21e-05	0.00054	CcSEcCtD
Droperidol—Anaphylactic shock—Hydrochlorothiazide—hypertension	7.21e-05	0.00054	CcSEcCtD
Droperidol—Dermatitis—Amlodipine—hypertension	7.2e-05	0.00054	CcSEcCtD
Droperidol—Dermatitis—Nisoldipine—hypertension	7.2e-05	0.00054	CcSEcCtD
Droperidol—Shock—Perindopril—hypertension	7.17e-05	0.000538	CcSEcCtD
Droperidol—Somnolence—Clonidine—hypertension	7.16e-05	0.000537	CcSEcCtD
Droperidol—Shock—Irbesartan—hypertension	7.15e-05	0.000536	CcSEcCtD
Droperidol—Tachycardia—Perindopril—hypertension	7.11e-05	0.000533	CcSEcCtD
Droperidol—Dizziness—Metoprolol—hypertension	7.11e-05	0.000533	CcSEcCtD
Droperidol—Dizziness—Guanabenz—hypertension	7.11e-05	0.000533	CcSEcCtD
Droperidol—Anxiety—Losartan—hypertension	7.11e-05	0.000533	CcSEcCtD
Droperidol—Tachycardia—Irbesartan—hypertension	7.09e-05	0.000532	CcSEcCtD
Droperidol—Shock—Hydrochlorothiazide—hypertension	7.09e-05	0.000531	CcSEcCtD
Droperidol—Anaphylactic shock—Furosemide—hypertension	7.09e-05	0.000531	CcSEcCtD
Droperidol—Hypersensitivity—Indapamide—hypertension	7.04e-05	0.000528	CcSEcCtD
Droperidol—Hypersensitivity—Diltiazem—hypertension	7.04e-05	0.000528	CcSEcCtD
Droperidol—Tachycardia—Hydrochlorothiazide—hypertension	7.03e-05	0.000527	CcSEcCtD
Droperidol—Hypotension—Captopril—hypertension	7.01e-05	0.000526	CcSEcCtD
Droperidol—Somnolence—Trandolapril—hypertension	6.99e-05	0.000524	CcSEcCtD
Droperidol—Shock—Furosemide—hypertension	6.97e-05	0.000523	CcSEcCtD
Droperidol—Hypersensitivity—Carvedilol—hypertension	6.97e-05	0.000523	CcSEcCtD
Droperidol—Somnolence—Enalapril—hypertension	6.96e-05	0.000522	CcSEcCtD
Droperidol—Shock—Betaxolol—hypertension	6.9e-05	0.000517	CcSEcCtD
Droperidol—Hypersensitivity—Doxazosin—hypertension	6.89e-05	0.000517	CcSEcCtD
Droperidol—Somnolence—Telmisartan—hypertension	6.86e-05	0.000515	CcSEcCtD
Droperidol—Tachycardia—Betaxolol—hypertension	6.85e-05	0.000513	CcSEcCtD
Droperidol—Anaphylactic shock—Losartan—hypertension	6.84e-05	0.000513	CcSEcCtD
Droperidol—Hypotension—Perindopril—hypertension	6.81e-05	0.000511	CcSEcCtD
Droperidol—Hypersensitivity—Fosinopril—hypertension	6.81e-05	0.00051	CcSEcCtD
Droperidol—Hypotension—Irbesartan—hypertension	6.79e-05	0.000509	CcSEcCtD
Droperidol—Rash—Metoprolol—hypertension	6.78e-05	0.000508	CcSEcCtD
Droperidol—Rash—Guanabenz—hypertension	6.78e-05	0.000508	CcSEcCtD
Droperidol—Dermatitis—Guanabenz—hypertension	6.77e-05	0.000508	CcSEcCtD
Droperidol—Dermatitis—Metoprolol—hypertension	6.77e-05	0.000508	CcSEcCtD
Droperidol—Hypotension—Hydrochlorothiazide—hypertension	6.73e-05	0.000505	CcSEcCtD
Droperidol—Shock—Losartan—hypertension	6.73e-05	0.000504	CcSEcCtD
Droperidol—Hypersensitivity—Nifedipine—hypertension	6.72e-05	0.000504	CcSEcCtD
Droperidol—Chills—Lisinopril—hypertension	6.71e-05	0.000503	CcSEcCtD
Droperidol—Hypersensitivity—Verapamil—hypertension	6.69e-05	0.000501	CcSEcCtD
Droperidol—Somnolence—Captopril—hypertension	6.67e-05	0.0005	CcSEcCtD
Droperidol—Tachycardia—Losartan—hypertension	6.67e-05	0.0005	CcSEcCtD
Droperidol—Body temperature increased—Olmesartan—hypertension	6.65e-05	0.000499	CcSEcCtD
Droperidol—Haloperidol—HTR2A—hypertension	6.63e-05	0.018	CrCbGaD
Droperidol—Hypotension—Furosemide—hypertension	6.62e-05	0.000496	CcSEcCtD
Droperidol—Angioedema—Ramipril—hypertension	6.56e-05	0.000492	CcSEcCtD
Droperidol—Hypotension—Betaxolol—hypertension	6.56e-05	0.000491	CcSEcCtD
Droperidol—Dizziness—Propranolol—hypertension	6.53e-05	0.000489	CcSEcCtD
Droperidol—Somnolence—Perindopril—hypertension	6.48e-05	0.000486	CcSEcCtD
Droperidol—Somnolence—Irbesartan—hypertension	6.46e-05	0.000484	CcSEcCtD
Droperidol—Syncope—Ramipril—hypertension	6.44e-05	0.000483	CcSEcCtD
Droperidol—Angioedema—Timolol—hypertension	6.42e-05	0.000481	CcSEcCtD
Droperidol—Somnolence—Hydrochlorothiazide—hypertension	6.41e-05	0.00048	CcSEcCtD
Droperidol—Hypotension—Losartan—hypertension	6.39e-05	0.000479	CcSEcCtD
Droperidol—Body temperature increased—Clonidine—hypertension	6.37e-05	0.000478	CcSEcCtD
Droperidol—Palpitations—Ramipril—hypertension	6.35e-05	0.000476	CcSEcCtD
Droperidol—Dizziness—Indapamide—hypertension	6.32e-05	0.000474	CcSEcCtD
Droperidol—Dizziness—Diltiazem—hypertension	6.32e-05	0.000474	CcSEcCtD
Droperidol—Loss of consciousness—Ramipril—hypertension	6.31e-05	0.000473	CcSEcCtD
Droperidol—Somnolence—Furosemide—hypertension	6.3e-05	0.000472	CcSEcCtD
Droperidol—Syncope—Timolol—hypertension	6.3e-05	0.000472	CcSEcCtD
Droperidol—Dizziness—Carvedilol—hypertension	6.26e-05	0.000469	CcSEcCtD
Droperidol—Hypersensitivity—Valsartan—hypertension	6.23e-05	0.000467	CcSEcCtD
Droperidol—Rash—Propranolol—hypertension	6.22e-05	0.000467	CcSEcCtD
Droperidol—Dermatitis—Propranolol—hypertension	6.22e-05	0.000466	CcSEcCtD
Droperidol—Body temperature increased—Trandolapril—hypertension	6.21e-05	0.000466	CcSEcCtD
Droperidol—Palpitations—Timolol—hypertension	6.21e-05	0.000465	CcSEcCtD
Droperidol—Body temperature increased—Enalapril—hypertension	6.19e-05	0.000464	CcSEcCtD
Droperidol—Dizziness—Doxazosin—hypertension	6.19e-05	0.000464	CcSEcCtD
Droperidol—Loss of consciousness—Timolol—hypertension	6.17e-05	0.000463	CcSEcCtD
Droperidol—Dizziness—Fosinopril—hypertension	6.11e-05	0.000458	CcSEcCtD
Droperidol—Body temperature increased—Telmisartan—hypertension	6.1e-05	0.000458	CcSEcCtD
Droperidol—Anxiety—Ramipril—hypertension	6.09e-05	0.000457	CcSEcCtD
Droperidol—Somnolence—Losartan—hypertension	6.08e-05	0.000456	CcSEcCtD
Droperidol—Dizziness—Eplerenone—hypertension	6.08e-05	0.000455	CcSEcCtD
Droperidol—Hypertension—Timolol—hypertension	6.06e-05	0.000454	CcSEcCtD
Droperidol—Dizziness—Nifedipine—hypertension	6.03e-05	0.000452	CcSEcCtD
Droperidol—Rash—Indapamide—hypertension	6.02e-05	0.000452	CcSEcCtD
Droperidol—Rash—Diltiazem—hypertension	6.02e-05	0.000452	CcSEcCtD
Droperidol—Dermatitis—Indapamide—hypertension	6.02e-05	0.000451	CcSEcCtD
Droperidol—Dermatitis—Diltiazem—hypertension	6.02e-05	0.000451	CcSEcCtD
Droperidol—Dizziness—Verapamil—hypertension	6e-05	0.00045	CcSEcCtD
Droperidol—Rash—Carvedilol—hypertension	5.97e-05	0.000447	CcSEcCtD
Droperidol—Dermatitis—Carvedilol—hypertension	5.96e-05	0.000447	CcSEcCtD
Droperidol—Anxiety—Timolol—hypertension	5.96e-05	0.000447	CcSEcCtD
Droperidol—Angioedema—Lisinopril—hypertension	5.95e-05	0.000446	CcSEcCtD
Droperidol—Hypersensitivity—Clonidine—hypertension	5.94e-05	0.000445	CcSEcCtD
Droperidol—Body temperature increased—Captopril—hypertension	5.93e-05	0.000445	CcSEcCtD
Droperidol—Rash—Doxazosin—hypertension	5.9e-05	0.000442	CcSEcCtD
Droperidol—Dermatitis—Doxazosin—hypertension	5.89e-05	0.000442	CcSEcCtD
Droperidol—Anaphylactic shock—Ramipril—hypertension	5.86e-05	0.000439	CcSEcCtD
Droperidol—Syncope—Lisinopril—hypertension	5.84e-05	0.000438	CcSEcCtD
Droperidol—Rash—Fosinopril—hypertension	5.83e-05	0.000437	CcSEcCtD
Droperidol—Dermatitis—Fosinopril—hypertension	5.82e-05	0.000436	CcSEcCtD
Droperidol—Rash—Eplerenone—hypertension	5.79e-05	0.000434	CcSEcCtD
Droperidol—Hypersensitivity—Trandolapril—hypertension	5.79e-05	0.000434	CcSEcCtD
Droperidol—Dermatitis—Eplerenone—hypertension	5.79e-05	0.000434	CcSEcCtD
Droperidol—Shock—Ramipril—hypertension	5.77e-05	0.000432	CcSEcCtD
Droperidol—Hypersensitivity—Enalapril—hypertension	5.77e-05	0.000432	CcSEcCtD
Droperidol—Body temperature increased—Perindopril—hypertension	5.76e-05	0.000432	CcSEcCtD
Droperidol—Palpitations—Lisinopril—hypertension	5.76e-05	0.000432	CcSEcCtD
Droperidol—Rash—Nifedipine—hypertension	5.75e-05	0.000431	CcSEcCtD
Droperidol—Dermatitis—Nifedipine—hypertension	5.74e-05	0.000431	CcSEcCtD
Droperidol—Body temperature increased—Irbesartan—hypertension	5.74e-05	0.000431	CcSEcCtD
Droperidol—Anaphylactic shock—Timolol—hypertension	5.73e-05	0.00043	CcSEcCtD
Droperidol—Loss of consciousness—Lisinopril—hypertension	5.73e-05	0.000429	CcSEcCtD
Droperidol—Rash—Verapamil—hypertension	5.72e-05	0.000429	CcSEcCtD
Droperidol—Tachycardia—Ramipril—hypertension	5.72e-05	0.000429	CcSEcCtD
Droperidol—Dermatitis—Verapamil—hypertension	5.72e-05	0.000429	CcSEcCtD
Droperidol—Body temperature increased—Hydrochlorothiazide—hypertension	5.7e-05	0.000427	CcSEcCtD
Droperidol—Hypersensitivity—Telmisartan—hypertension	5.69e-05	0.000426	CcSEcCtD
Droperidol—Shock—Timolol—hypertension	5.64e-05	0.000423	CcSEcCtD
Droperidol—Body temperature increased—Furosemide—hypertension	5.6e-05	0.00042	CcSEcCtD
Droperidol—Dizziness—Valsartan—hypertension	5.59e-05	0.000419	CcSEcCtD
Droperidol—Dizziness—Olmesartan—hypertension	5.56e-05	0.000417	CcSEcCtD
Droperidol—Body temperature increased—Betaxolol—hypertension	5.55e-05	0.000416	CcSEcCtD
Droperidol—Anxiety—Lisinopril—hypertension	5.53e-05	0.000414	CcSEcCtD
Droperidol—Hypotension—Ramipril—hypertension	5.48e-05	0.000411	CcSEcCtD
Droperidol—Body temperature increased—Losartan—hypertension	5.4e-05	0.000405	CcSEcCtD
Droperidol—Hypotension—Timolol—hypertension	5.36e-05	0.000401	CcSEcCtD
Droperidol—Hypersensitivity—Irbesartan—hypertension	5.35e-05	0.000401	CcSEcCtD
Droperidol—Rash—Valsartan—hypertension	5.33e-05	0.0004	CcSEcCtD
Droperidol—Dizziness—Clonidine—hypertension	5.33e-05	0.000399	CcSEcCtD
Droperidol—Dermatitis—Valsartan—hypertension	5.32e-05	0.000399	CcSEcCtD
Droperidol—Anaphylactic shock—Lisinopril—hypertension	5.32e-05	0.000399	CcSEcCtD
Droperidol—Hypersensitivity—Hydrochlorothiazide—hypertension	5.31e-05	0.000398	CcSEcCtD
Droperidol—Rash—Olmesartan—hypertension	5.3e-05	0.000398	CcSEcCtD
Droperidol—Dermatitis—Olmesartan—hypertension	5.3e-05	0.000397	CcSEcCtD
Droperidol—Shock—Lisinopril—hypertension	5.23e-05	0.000392	CcSEcCtD
Droperidol—Hypersensitivity—Furosemide—hypertension	5.22e-05	0.000391	CcSEcCtD
Droperidol—Somnolence—Ramipril—hypertension	5.21e-05	0.000391	CcSEcCtD
Droperidol—Dizziness—Trandolapril—hypertension	5.2e-05	0.00039	CcSEcCtD
Droperidol—Tachycardia—Lisinopril—hypertension	5.19e-05	0.000389	CcSEcCtD
Droperidol—Dizziness—Enalapril—hypertension	5.18e-05	0.000388	CcSEcCtD
Droperidol—Hypersensitivity—Betaxolol—hypertension	5.17e-05	0.000387	CcSEcCtD
Droperidol—Dizziness—Telmisartan—hypertension	5.11e-05	0.000383	CcSEcCtD
Droperidol—Somnolence—Timolol—hypertension	5.09e-05	0.000382	CcSEcCtD
Droperidol—Rash—Clonidine—hypertension	5.08e-05	0.000381	CcSEcCtD
Droperidol—Dermatitis—Clonidine—hypertension	5.08e-05	0.000381	CcSEcCtD
Droperidol—Hypersensitivity—Losartan—hypertension	5.04e-05	0.000378	CcSEcCtD
Droperidol—Hypotension—Lisinopril—hypertension	4.97e-05	0.000372	CcSEcCtD
Droperidol—Dizziness—Captopril—hypertension	4.96e-05	0.000372	CcSEcCtD
Droperidol—Rash—Trandolapril—hypertension	4.95e-05	0.000371	CcSEcCtD
Droperidol—Dermatitis—Trandolapril—hypertension	4.95e-05	0.000371	CcSEcCtD
Droperidol—Rash—Enalapril—hypertension	4.94e-05	0.00037	CcSEcCtD
Droperidol—Dermatitis—Enalapril—hypertension	4.93e-05	0.00037	CcSEcCtD
Droperidol—Rash—Telmisartan—hypertension	4.87e-05	0.000365	CcSEcCtD
Droperidol—Dermatitis—Telmisartan—hypertension	4.86e-05	0.000365	CcSEcCtD
Droperidol—Dizziness—Perindopril—hypertension	4.82e-05	0.000361	CcSEcCtD
Droperidol—Dizziness—Irbesartan—hypertension	4.8e-05	0.00036	CcSEcCtD
Droperidol—Dizziness—Hydrochlorothiazide—hypertension	4.76e-05	0.000357	CcSEcCtD
Droperidol—Rash—Captopril—hypertension	4.73e-05	0.000355	CcSEcCtD
Droperidol—Dermatitis—Captopril—hypertension	4.73e-05	0.000355	CcSEcCtD
Droperidol—Somnolence—Lisinopril—hypertension	4.73e-05	0.000354	CcSEcCtD
Droperidol—Dizziness—Furosemide—hypertension	4.69e-05	0.000351	CcSEcCtD
Droperidol—Dizziness—Betaxolol—hypertension	4.64e-05	0.000348	CcSEcCtD
Droperidol—Body temperature increased—Ramipril—hypertension	4.63e-05	0.000347	CcSEcCtD
Droperidol—Rash—Perindopril—hypertension	4.6e-05	0.000345	CcSEcCtD
Droperidol—Dermatitis—Perindopril—hypertension	4.59e-05	0.000344	CcSEcCtD
Droperidol—Rash—Irbesartan—hypertension	4.58e-05	0.000343	CcSEcCtD
Droperidol—Dermatitis—Irbesartan—hypertension	4.58e-05	0.000343	CcSEcCtD
Droperidol—Rash—Hydrochlorothiazide—hypertension	4.54e-05	0.000341	CcSEcCtD
Droperidol—Dermatitis—Hydrochlorothiazide—hypertension	4.54e-05	0.00034	CcSEcCtD
Droperidol—Body temperature increased—Timolol—hypertension	4.53e-05	0.00034	CcSEcCtD
Droperidol—Dizziness—Losartan—hypertension	4.52e-05	0.000339	CcSEcCtD
Droperidol—Rash—Furosemide—hypertension	4.47e-05	0.000335	CcSEcCtD
Droperidol—Dermatitis—Furosemide—hypertension	4.46e-05	0.000335	CcSEcCtD
Droperidol—Rash—Betaxolol—hypertension	4.42e-05	0.000332	CcSEcCtD
Droperidol—Dermatitis—Betaxolol—hypertension	4.42e-05	0.000331	CcSEcCtD
Droperidol—Hypersensitivity—Ramipril—hypertension	4.32e-05	0.000324	CcSEcCtD
Droperidol—Rash—Losartan—hypertension	4.31e-05	0.000323	CcSEcCtD
Droperidol—Dermatitis—Losartan—hypertension	4.31e-05	0.000323	CcSEcCtD
Droperidol—Hypersensitivity—Timolol—hypertension	4.22e-05	0.000317	CcSEcCtD
Droperidol—Body temperature increased—Lisinopril—hypertension	4.2e-05	0.000315	CcSEcCtD
Droperidol—Hypersensitivity—Lisinopril—hypertension	3.92e-05	0.000294	CcSEcCtD
Droperidol—Dizziness—Ramipril—hypertension	3.88e-05	0.000291	CcSEcCtD
Droperidol—Dizziness—Timolol—hypertension	3.79e-05	0.000284	CcSEcCtD
Droperidol—Rash—Ramipril—hypertension	3.7e-05	0.000277	CcSEcCtD
Droperidol—Dermatitis—Ramipril—hypertension	3.69e-05	0.000277	CcSEcCtD
Droperidol—Rash—Timolol—hypertension	3.61e-05	0.000271	CcSEcCtD
Droperidol—Dermatitis—Timolol—hypertension	3.61e-05	0.000271	CcSEcCtD
Droperidol—Dizziness—Lisinopril—hypertension	3.52e-05	0.000264	CcSEcCtD
Droperidol—Rash—Lisinopril—hypertension	3.35e-05	0.000251	CcSEcCtD
Droperidol—Dermatitis—Lisinopril—hypertension	3.35e-05	0.000251	CcSEcCtD
Droperidol—DRD2—Signaling Pathways—PLG—hypertension	4.86e-06	6.85e-05	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—RHOA—hypertension	4.86e-06	6.84e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ITGAV—hypertension	4.85e-06	6.83e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NGFR—hypertension	4.85e-06	6.83e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—STK11—hypertension	4.84e-06	6.81e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HDAC1—hypertension	4.84e-06	6.81e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KNG1—hypertension	4.84e-06	6.81e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—POMC—hypertension	4.82e-06	6.79e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CCL2—hypertension	4.82e-06	6.78e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AKT2—hypertension	4.81e-06	6.77e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AGTR1—hypertension	4.81e-06	6.77e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRL—hypertension	4.81e-06	6.77e-05	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3R1—hypertension	4.81e-06	6.76e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCL10—hypertension	4.8e-06	6.76e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PLG—hypertension	4.79e-06	6.74e-05	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—RHOA—hypertension	4.78e-06	6.73e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—STK11—hypertension	4.74e-06	6.67e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HDAC1—hypertension	4.74e-06	6.67e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADRB2—hypertension	4.73e-06	6.66e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AKT2—hypertension	4.73e-06	6.66e-05	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3R1—hypertension	4.73e-06	6.66e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CCL2—hypertension	4.72e-06	6.64e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCL10—hypertension	4.7e-06	6.61e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PLG—hypertension	4.69e-06	6.6e-05	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—RHOA—hypertension	4.68e-06	6.59e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKCE—hypertension	4.67e-06	6.58e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADRB2—hypertension	4.66e-06	6.56e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AKT2—hypertension	4.63e-06	6.52e-05	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3R1—hypertension	4.63e-06	6.52e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PDGFA—hypertension	4.62e-06	6.5e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—VAV3—hypertension	4.62e-06	6.5e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKCE—hypertension	4.6e-06	6.47e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADRB2—hypertension	4.56e-06	6.42e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TGFBR2—hypertension	4.55e-06	6.41e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PDGFA—hypertension	4.54e-06	6.39e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—VAV3—hypertension	4.54e-06	6.39e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GNB3—hypertension	4.51e-06	6.35e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKCE—hypertension	4.5e-06	6.34e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TGFBR2—hypertension	4.48e-06	6.3e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—VAV3—hypertension	4.45e-06	6.26e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PDGFA—hypertension	4.45e-06	6.26e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AVP—hypertension	4.45e-06	6.26e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GNB3—hypertension	4.44e-06	6.25e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—RHOA—hypertension	4.41e-06	6.21e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—GNAS—hypertension	4.39e-06	6.18e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TGFBR2—hypertension	4.39e-06	6.17e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AVP—hypertension	4.38e-06	6.16e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3R1—hypertension	4.36e-06	6.14e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GNB3—hypertension	4.34e-06	6.12e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—RHOA—hypertension	4.34e-06	6.11e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GNAS—hypertension	4.32e-06	6.08e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOB—hypertension	4.3e-06	6.05e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3R1—hypertension	4.29e-06	6.04e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AVP—hypertension	4.29e-06	6.03e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PTK2—hypertension	4.28e-06	6.03e-05	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CXCL8—hypertension	4.26e-06	6e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—RHOA—hypertension	4.25e-06	5.98e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EDN1—hypertension	4.23e-06	5.96e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOB—hypertension	4.23e-06	5.95e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GNAS—hypertension	4.23e-06	5.95e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PTK2—hypertension	4.21e-06	5.93e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3R1—hypertension	4.2e-06	5.92e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCL5—hypertension	4.2e-06	5.91e-05	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CXCL8—hypertension	4.19e-06	5.9e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EDN1—hypertension	4.16e-06	5.86e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOB—hypertension	4.14e-06	5.83e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCL5—hypertension	4.13e-06	5.81e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PTK2—hypertension	4.13e-06	5.81e-05	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CXCL8—hypertension	4.11e-06	5.78e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LPL—hypertension	4.11e-06	5.78e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EDN1—hypertension	4.08e-06	5.74e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—H2AFX—hypertension	4.08e-06	5.74e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PDGFRB—hypertension	4.07e-06	5.73e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RPS6KB1—hypertension	4.07e-06	5.73e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCL5—hypertension	4.05e-06	5.69e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LPL—hypertension	4.04e-06	5.69e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ADCY5—hypertension	4.02e-06	5.66e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—H2AFX—hypertension	4.01e-06	5.65e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PDGFRB—hypertension	4e-06	5.64e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RPS6KB1—hypertension	4e-06	5.64e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKCG—hypertension	3.99e-06	5.62e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKCA—hypertension	3.96e-06	5.58e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ITGB3—hypertension	3.96e-06	5.58e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LPL—hypertension	3.96e-06	5.57e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ADCY5—hypertension	3.95e-06	5.57e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—YWHAZ—hypertension	3.93e-06	5.54e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKCG—hypertension	3.93e-06	5.53e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—H2AFX—hypertension	3.93e-06	5.53e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PDGFRB—hypertension	3.92e-06	5.52e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RPS6KB1—hypertension	3.92e-06	5.52e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ITGB3—hypertension	3.9e-06	5.49e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKCA—hypertension	3.9e-06	5.49e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SPP1—hypertension	3.89e-06	5.47e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NGF—hypertension	3.89e-06	5.47e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ADCY5—hypertension	3.87e-06	5.45e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CXCL8—hypertension	3.87e-06	5.45e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—YWHAZ—hypertension	3.87e-06	5.45e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKCG—hypertension	3.85e-06	5.41e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NGF—hypertension	3.83e-06	5.39e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SPP1—hypertension	3.83e-06	5.39e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ITGB3—hypertension	3.82e-06	5.38e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKCA—hypertension	3.82e-06	5.38e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CXCL8—hypertension	3.81e-06	5.36e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—YWHAZ—hypertension	3.79e-06	5.33e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCR5—hypertension	3.78e-06	5.32e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKCD—hypertension	3.78e-06	5.32e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SPP1—hypertension	3.75e-06	5.27e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NGF—hypertension	3.75e-06	5.27e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CXCL8—hypertension	3.73e-06	5.25e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCR5—hypertension	3.72e-06	5.24e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKCD—hypertension	3.72e-06	5.24e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HTR2A—hypertension	3.7e-06	5.21e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—C3—hypertension	3.7e-06	5.2e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKCD—hypertension	3.64e-06	5.13e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCR5—hypertension	3.64e-06	5.13e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—C3—hypertension	3.64e-06	5.12e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PDGFB—hypertension	3.6e-06	5.06e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGFR1—hypertension	3.58e-06	5.04e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HTR2A—hypertension	3.57e-06	5.02e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—C3—hypertension	3.56e-06	5.01e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PDGFB—hypertension	3.54e-06	4.98e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HIF1A—hypertension	3.53e-06	4.96e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGFR1—hypertension	3.52e-06	4.96e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AGT—hypertension	3.51e-06	4.94e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HIF1A—hypertension	3.47e-06	4.88e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PDGFB—hypertension	3.47e-06	4.88e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AGT—hypertension	3.46e-06	4.86e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CALM1—hypertension	3.45e-06	4.86e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGFR1—hypertension	3.45e-06	4.85e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—LEP—hypertension	3.44e-06	4.84e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOE—hypertension	3.44e-06	4.84e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CAV1—hypertension	3.41e-06	4.8e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APOA1—hypertension	3.4e-06	4.79e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CALM1—hypertension	3.4e-06	4.78e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HIF1A—hypertension	3.4e-06	4.78e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—LEP—hypertension	3.39e-06	4.77e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOE—hypertension	3.39e-06	4.77e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AGT—hypertension	3.38e-06	4.76e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—KDR—hypertension	3.37e-06	4.75e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CAV1—hypertension	3.35e-06	4.72e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APOA1—hypertension	3.35e-06	4.71e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CALM1—hypertension	3.33e-06	4.68e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—KDR—hypertension	3.32e-06	4.67e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—LEP—hypertension	3.32e-06	4.67e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOE—hypertension	3.32e-06	4.67e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CAV1—hypertension	3.28e-06	4.62e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APOA1—hypertension	3.28e-06	4.61e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KDR—hypertension	3.25e-06	4.57e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKCB—hypertension	3.25e-06	4.57e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FN1—hypertension	3.25e-06	4.57e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—F2—hypertension	3.25e-06	4.57e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKCB—hypertension	3.19e-06	4.49e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—F2—hypertension	3.19e-06	4.49e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FN1—hypertension	3.19e-06	4.49e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NOTCH1—hypertension	3.18e-06	4.47e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FN1—hypertension	3.13e-06	4.4e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—F2—hypertension	3.13e-06	4.4e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKCB—hypertension	3.13e-06	4.4e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NOTCH1—hypertension	3.12e-06	4.4e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NOTCH1—hypertension	3.06e-06	4.31e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—POMC—hypertension	2.96e-06	4.16e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—INS—hypertension	2.94e-06	4.14e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—POMC—hypertension	2.91e-06	4.09e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—INS—hypertension	2.89e-06	4.07e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCL2—hypertension	2.89e-06	4.07e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—POMC—hypertension	2.85e-06	4.01e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCL2—hypertension	2.85e-06	4.01e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF1—hypertension	2.84e-06	4e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKT2—hypertension	2.84e-06	4e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—INS—hypertension	2.83e-06	3.99e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—EGFR—hypertension	2.83e-06	3.98e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF1—hypertension	2.8e-06	3.94e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKT2—hypertension	2.8e-06	3.94e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCL2—hypertension	2.79e-06	3.92e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—EGFR—hypertension	2.78e-06	3.92e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF1—hypertension	2.74e-06	3.86e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKT2—hypertension	2.74e-06	3.85e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—EGFR—hypertension	2.73e-06	3.84e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SERPINE1—hypertension	2.7e-06	3.8e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SERPINE1—hypertension	2.66e-06	3.74e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGF2—hypertension	2.61e-06	3.68e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RHOA—hypertension	2.6e-06	3.67e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SERPINE1—hypertension	2.6e-06	3.66e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NOS3—hypertension	2.58e-06	3.63e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3R1—hypertension	2.58e-06	3.63e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGF2—hypertension	2.57e-06	3.62e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RHOA—hypertension	2.56e-06	3.61e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NOS3—hypertension	2.54e-06	3.57e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3R1—hypertension	2.54e-06	3.57e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGF2—hypertension	2.52e-06	3.55e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RHOA—hypertension	2.51e-06	3.53e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3R1—hypertension	2.48e-06	3.5e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NOS3—hypertension	2.48e-06	3.5e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RELA—hypertension	2.43e-06	3.42e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RELA—hypertension	2.39e-06	3.36e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MTOR—hypertension	2.38e-06	3.35e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MTOR—hypertension	2.34e-06	3.3e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RELA—hypertension	2.34e-06	3.29e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MTOR—hypertension	2.29e-06	3.23e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCL8—hypertension	2.29e-06	3.22e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCL8—hypertension	2.25e-06	3.17e-05	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AKT1—hypertension	2.21e-06	3.11e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCL8—hypertension	2.2e-06	3.1e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6—hypertension	2.17e-06	3.06e-05	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AKT1—hypertension	2.17e-06	3.06e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6—hypertension	2.14e-06	3.01e-05	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AKT1—hypertension	2.13e-06	3e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6—hypertension	2.1e-06	2.95e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MMP9—hypertension	2.07e-06	2.91e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CDKN1A—hypertension	2.06e-06	2.9e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PTEN—hypertension	2.06e-06	2.89e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MMP9—hypertension	2.04e-06	2.86e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CDKN1A—hypertension	2.03e-06	2.85e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PTEN—hypertension	2.02e-06	2.85e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAPK8—hypertension	2.01e-06	2.83e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AKT1—hypertension	2.01e-06	2.82e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MMP9—hypertension	1.99e-06	2.81e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CDKN1A—hypertension	1.99e-06	2.8e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PTEN—hypertension	1.98e-06	2.79e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAPK8—hypertension	1.98e-06	2.79e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AKT1—hypertension	1.97e-06	2.78e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EP300—hypertension	1.96e-06	2.76e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAPK8—hypertension	1.94e-06	2.73e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AKT1—hypertension	1.93e-06	2.72e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EP300—hypertension	1.93e-06	2.72e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SRC—hypertension	1.91e-06	2.68e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EP300—hypertension	1.89e-06	2.66e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SRC—hypertension	1.88e-06	2.64e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—VEGFA—hypertension	1.86e-06	2.61e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SRC—hypertension	1.84e-06	2.59e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—VEGFA—hypertension	1.83e-06	2.57e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—VEGFA—hypertension	1.79e-06	2.52e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MYC—hypertension	1.71e-06	2.41e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TGFB1—hypertension	1.7e-06	2.4e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MYC—hypertension	1.68e-06	2.37e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TGFB1—hypertension	1.68e-06	2.36e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EGFR—hypertension	1.67e-06	2.35e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MYC—hypertension	1.65e-06	2.32e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EGFR—hypertension	1.64e-06	2.31e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TGFB1—hypertension	1.64e-06	2.31e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EGFR—hypertension	1.61e-06	2.27e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TP53—hypertension	1.4e-06	1.98e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TP53—hypertension	1.38e-06	1.94e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TP53—hypertension	1.35e-06	1.9e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6—hypertension	1.28e-06	1.81e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6—hypertension	1.26e-06	1.78e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6—hypertension	1.24e-06	1.74e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKT1—hypertension	1.19e-06	1.67e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKT1—hypertension	1.17e-06	1.64e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKT1—hypertension	1.14e-06	1.61e-05	CbGpPWpGaD
